The treatment of choice for a localized, solitary plasmacytoma in the absence of osteolytic lesions or other features of multiple myeloma is tumoricidal radiation at a dose of 40 Gy over a 4-week ...

A bone scan 4 months later showed bony metastasis at multiple ribs ... chemorefractory multiple myeloma, even at the stage of terminal illness with extramedullary plasmacytoma.

We have previously demonstrated that interleukin-17A (IL-17) producing T helper 17 cells are significantly elevated in blood and bone marrow (BM) in multiple myeloma (MM) and IL-17A promotes MM ...

Solitary plasmacytoma, a rare form of bone cancer affecting plasma cells, may also increase the risk. It is similar to multiple myeloma, but in solitary plasmacytoma, a single tumor is present.

Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are white blood cells that help you fight infection by making antibodies. Multiple myeloma starts in the plasma cells ...

Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are white blood cells that help you fight infection by making antibodies. Multiple myeloma starts in the plasma ...

It is important to note that multiple myeloma can also lead to the development of other related conditions, such as monoclonal gammopathy of undetermined significance (MGUS), plasmacytoma ...

Were exposed to pesticides. We do not know what causes MGUS. There may be a link to autoimmune diseases, genetics, or environmental factors. Like multiple myeloma, MGUS starts in a type of white blood ...